Aktiesnakken — August 2010
-
man må ikke håbe at resten af dansk biotek skal handles til cash værdi
-
så skal neurosearch under 25
-
aka det håber jeg sgu ikke at Neu skal derned
-
og frem ad rettet er genmabs burn endog lavere
-
nu har du selvføgelig ikke haft ret de seneste par mdr omkring GEN så, når du siger at NEU så må det jo betyde op
-
historisk
e fejl er ingen garanti for fremtidige -
er der slet ingen der stiller kurser i capi?
-
men vores realtid er screwed, har den fået ny ticker
-
det er fordi jeg har en større short position i porteføljen
-
ja det er korrekt at genmab planlægger et strategi update der
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind